Cellular & Molecular Biology Letters

Papers
(The TQCC of Cellular & Molecular Biology Letters is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review192
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC172
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment137
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway121
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery114
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development107
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges98
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects98
Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis97
lncRNA PVT1: a novel oncogene in multiple cancers78
Osteoporosis pathogenesis and treatment: existing and emerging avenues73
5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo69
Melatonin and cancer suppression: insights into its effects on DNA methylation63
Integrated analysis of tRNA-derived small RNAs in proliferative human aortic smooth muscle cells63
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L62
Reversely immortalized mouse salivary gland cells presented a promising metabolic and fibrotic response upon BMP9/Gdf2 stimulation58
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress55
Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma43
0.11476016044617